Literature DB >> 2923484

Prediction and diagnosis of sickling disorders in neonates.

N Adjaye1, B J Bain, P Steer.   

Abstract

A pilot scheme for the prediction and detection of sickle cell disease in neonates was set up and the results from its first three years of operation analysed. A total of 153 women booking at the antenatal clinic were found to have haemoglobin S. The protocol required that all partners of the women so identified be screened for abnormal haemoglobins and beta thalassaemia trait, and that the babies of these women should have cord blood electrophoresis performed. In fact this was only achieved in 75 partners (49%) and 91 of 145 infants (63%). Of 10 babies born with sickle cell disease during the study period, nine had mothers known to have haemoglobin S or C, but only four of these mothers' partners had been tested before delivery of the child. This pilot study highlights the problems in establishing effective antenatal screening programmes, especially in ethnic minority groups. The results show that detailed staff training, careful organisation of administrative arrangements, and education of 'at risk' groups should all be undertaken before the launching of major screening initiatives.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923484      PMCID: PMC1590068          DOI: 10.1136/adc.64.1_spec_no.39

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Neonatal screening for haemoglobinopathy. Results in 7691 Manchester newborns.

Authors:  D I Evans; V M Blair
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

2.  Diagnosis of haemoglobinopathy using cultured chorionic villus cells.

Authors:  D H Horwell; D E Heaton; J M Old
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

3.  Screening cord blood for sickle haemoglobinopathies in Brent.

Authors:  J Henthorn; E Anionwu; M Brozovic
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-25

4.  Prevention of pneumococcal infection in children with homozygous sickle cell disease.

Authors:  A B John; A Ramlal; H Jackson; G H Maude; A W Sharma; G R Serjeant
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-26

5.  Early deaths in Jamaican children with sickle cell disease.

Authors:  D W Rogers; J M Clarke; L Cupidore; A M Ramlal; B R Sparke; G R Serjeant
Journal:  Br Med J       Date:  1978-06-10

6.  Newborn screening for hemoglobinopathies in New York State: experience of physicians and parents of affected children.

Authors:  N S Warren; T P Carter; J R Humbert; P T Rowley
Journal:  J Pediatr       Date:  1982-03       Impact factor: 4.406

7.  Current sickle cell screening program for newborns in New York City, 1979-1980.

Authors:  R Grover; S Shahidi; B Fisher; D Goldberg; D Wethers
Journal:  Am J Public Health       Date:  1983-03       Impact factor: 9.308

8.  Neonatal screening for sickle haemoglobinopathies in Birmingham.

Authors:  K D Griffiths; D N Raine; J R Mann
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27

9.  Screening of antenatal patients in a multiethnic community for beta thalassaemia trait.

Authors:  B J Bain
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

  9 in total
  6 in total

1.  Costing model for neonatal screening and diagnosis of haemoglobinopathies.

Authors:  E K Cronin; C Normand; J S Henthorn; M Hickman; S C Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-11       Impact factor: 5.747

2.  Neonatal screening of sickle cell anemia: a preliminary report.

Authors:  Sumanta Panigrahi; Predeep Kumar Patra; Prafulla Kumar Khodiar
Journal:  Indian J Pediatr       Date:  2012-01-26       Impact factor: 1.967

Review 3.  Neonatal screening for sickle cell disorders: what about the carrier infants?

Authors:  L Laird; C Dezateux; E N Anionwu
Journal:  BMJ       Date:  1996-08-17

4.  Services for people with haemoglobinopathy.

Authors:  S Davis
Journal:  BMJ       Date:  1994-04-23

5.  Prenatal genetic counseling for hemoglobinopathy carriers: a comparison of primary providers of prenatal care and professional genetic counselors.

Authors:  P T Rowley; S Loader; C J Sutera; A Kozyra
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

6.  Prenatal screening for hemoglobinopathies. III. Applicability of the health belief model.

Authors:  P T Rowley; S Loader; C J Sutera; M Walden; A Kozyra
Journal:  Am J Hum Genet       Date:  1991-03       Impact factor: 11.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.